Aug 24, 2023

Conversation around specific cardiovascular risks, while distinguishing between glycemic control and cardiovascular risk reduction. We will also highlight the benefits of treatment with GLP-1 RA in patients with diabetes.

Claim CE and MOC Credit at https://bit.ly/3SbyErW 

Aug 15, 2023

This activity focuses on the American Heart Association’s Essential 8 and glucose control. You will learn how GLP-1 RAs accelerate these glucose control goals and contribute to cardiorenal outcomes including how they work.

Claim CE and MOC Credit at 

Jul 20, 2023

HCM experts discuss the importance of shared decision-making in the treatment of patients with HCM with or at risk for arrhythmias, including patient perspectives. The prevalence of symptomatic and asymptomatic atrial fibrillation requires shared decision-making between patients and providers regarding initiation of...

Jun 14, 2023

When patients present with symptoms such as fatigue, fainting, shortness of breath, chest pain or heart palpitations without a known cause, suspect and test for HCM. In this episode, experts will discuss the best approaches for the management of symptoms in patients with HCM.  Lean more on identifying strategies...

May 24, 2023

In this episode, a panel of experts discuss identifying appropriate risk assessment strategies to accurately determine the level of VTE risk for patients.

Claim CE and MOC Credit at...